Novo Nordisk A S Income Statement (2015-2016) | NVO

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016
Revenue & cost
Revenue 3,808.00M4,004.00M3,991.00M4,240.00M4,017.00M4,165.00M
Cost of Revenue 586.00M570.00M573.00M678.00M625.00M614.00M
Gross Profit 3,222.00M3,434.00M3,418.00M3,562.00M3,392.00M3,551.00M
Operating items
Research & Development 491.00M448.00M491.00M593.00M488.00M505.00M
Restructuring Costs 129.00M131.00M142.00M171.00M134.00M133.00M
Operating Expenses 620.00M579.00M633.00M764.00M622.00M638.00M
Operating Income 2,094.00M1,843.00M1,784.00M1,629.00M1,817.00M1,895.00M
EBIT 2,094.00M1,843.00M1,784.00M1,629.00M1,817.00M1,895.00M
Non-operating items
Interest & Investment Income 43.00M-34.00M1.00M3.00M3.00M15.00M
Non Operating Income -208.00M-286.00M-275.00M-118.00M-52.00M15.00M
Net income details
EBT 1,886.00M1,557.00M1,509.00M1,511.00M1,765.00M1,910.00M
Profit After Tax 1,492.00M1,231.00M1,249.00M1,210.00M1,396.00M1,511.00M
Income from Continuing Operations 1,886.00M1,557.00M1,509.00M1,511.00M1,765.00M1,910.00M
Consolidated Net Income 1,886.00M1,557.00M1,509.00M1,511.00M1,765.00M1,910.00M
Income towards Parent Company 1,886.00M1,557.00M1,509.00M1,511.00M1,765.00M1,910.00M
Net Income towards Common Stockholders 1,886.00M1,557.00M1,509.00M1,511.00M1,765.00M1,910.00M
Additional items
EPS (Weighted Average and Diluted) 0.730.600.590.590.690.75
Shares Outstanding (Diluted Average) 2,596.70M2,578.10M2,565.90M2,553.20M2,544.30M2,536.30M
EBITDA 2,094.00M1,843.00M1,784.00M1,629.00M1,817.00M1,895.00M
Interest Expenses 251.00M252.00M276.00M121.00M55.00M